In vitro evaluation of biodegradable ε-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate

M. Ahola*, J. Rich, P. Kortesuo, J. Kiesvaara, J. Seppälä, A. Yli-Urpo

*Corresponding author for this work

    Research output: Contribution to journalArticleScientificpeer-review

    20 Citations (Scopus)

    Abstract

    Poly(ε-caprolactone-co-D,L-lactide) polymers were blended with toremifene citrate or with toremifene citrate impregnated silica xerogel in order to develop a controlled release formulation. The copolymers were synthesized by bulk polymerization and characterized by nuclear magnetic resonance, size exclusion chromatography and differential scanning calorimetry analyses. The in vitro release of toremifene citrate, an antiestrogenic compound, and silica was carried out in simulated body fluid (pH 7.4) containing 0.5 wt% sodium dodecylsulphate at 34°C. The in vitro release studies indicate that the release flux of toremifene citrate increases with increasing weight fraction of caprolactone in the copolymer. Silica xerogel had a minor enhancing effect on the release rate of toremifene citrate. Copolymers containing larger amounts of D,L-lactide (PLA-CL20 and PLA-CL40 copolymers) were not suitable matrices for the delivery of toremifene citrate in a controlled manner because of the burst effect. The fraction of toremifene citrate released from PLA-CL80 matrix increased with the increasing loading of toremifene citrate. The results of the study indicate that the in vitro release of toremifene citrate can be adjusted by varying the polymer composition and also the initial drug loading. Copyright (C) 1999 Elsevier Science B.V.

    Original languageEnglish
    Pages (from-to)181-191
    Number of pages11
    JournalInternational Journal of Pharmaceutics
    Volume181
    Issue number2
    DOIs
    Publication statusPublished - 30 Apr 1999
    MoE publication typeA1 Journal article-refereed

    Keywords

    • ε-Caprolactone/D,L-lactide copolymer
    • Biodegradable polymers
    • Drug release
    • Silica xerogel
    • Toremifene citrate

    Fingerprint Dive into the research topics of 'In vitro evaluation of biodegradable ε-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate'. Together they form a unique fingerprint.

  • Cite this